Health
BioNTech, Pfizer file for EU approval of COVID-19 vaccine – CGTN
On Tuesday, Germany’s BioNTech and its U.S. partner Pfizer said they had applied for EU regulatory approval for their COVID-19 vaccine, raising hopes that the first jabs could be administered in December.
The two companies said in a statement that they had submitted an application to the European Medicines Agency on Monday “for Conditional Marketing Authorization (CMA)” for their vaccine after tests showed it was 95 percent effective against the novel coronavirus.
If approved, the jab could potentially…
-
Noosa News24 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General24 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Business8 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General18 hours agoTribute unveiled for SA Police Brevet Sergeant Jason Doig after fatal 2023 shooting